Condition

Liposarcoma, Myxoid (2)

Leiomyosarcoma (1)

Liposarcoma (1)

Liposarcoma, Dedifferentiated (1)

Liposarcoma, Round Cell (1)

Pleomorphic Liposarcoma (1)

Sarcoma, Soft Tissue (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Grupo Espanol de Investigacion en Sarcomas (1)

Mario Negri Institute for Pharmacological Research (1)

Collaborator

Centre Leon Berard (1)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)

Humanitas Hospital, Italy (1)

Italian Sarcoma Group (1)

Intervention

trabectedin (2)

pioglitazone oral product (1)

radiotherapy (1)

Study Documents

Intervention Type

drug (2)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

Liposarcoma, Myxoid

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma Trial in France, Italy, Spain (Trabectedin, Radiotherapy)

Recruiting

Liposarcoma, Myxoid
+4 more

Trabectedin
Radiotherapy

Bordeaux, France
+15 more

Jun 6, 2022

Liposarcoma, Myxoid, Liposarcoma, Dedifferentiated, Liposarcoma, Round Cell Trial (Trabectedin, Pioglitazone Oral Product)

Not yet recruiting

Liposarcoma, Myxoid
+2 more

Trabectedin
Pioglitazone Oral Product

(no location specified)

Mar 10, 2021